| Amir Hanna, MD | |
|
175 Madison Ave, Mount Holly, NJ 08060-2038 | |
| (609) 261-1660 | |
| (609) 261-4454 |
| Full Name | Amir Hanna |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 26 Years |
| Location | 175 Madison Ave, Mount Holly, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376881920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25MA09144200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Jersey Healthcare Specialists Pc | 2668385253 | 554 |
News Archive
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Late-breaking data from the SPIRIT IV trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year.
Pregnancy can be a time of uncertainty for expecting mothers and their clinical care teams. Nearly 10 percent of births are preterm, taking place before 37 weeks gestation. Preterm birth can result from several conditions, including preterm labor, preterm rupture of the placental membrane, or preeclampsia.
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue.
› Verified 6 days ago
| Entity Name | New Jersey Healthcare Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174585780 PECOS PAC ID: 2668385253 Enrollment ID: O20031110000555 |
News Archive
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Late-breaking data from the SPIRIT IV trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year.
Pregnancy can be a time of uncertainty for expecting mothers and their clinical care teams. Nearly 10 percent of births are preterm, taking place before 37 weeks gestation. Preterm birth can result from several conditions, including preterm labor, preterm rupture of the placental membrane, or preeclampsia.
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue.
› Verified 6 days ago
| Entity Name | American Anesthesiology Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386654036 PECOS PAC ID: 0042112500 Enrollment ID: O20040123001039 |
News Archive
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Late-breaking data from the SPIRIT IV trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year.
Pregnancy can be a time of uncertainty for expecting mothers and their clinical care teams. Nearly 10 percent of births are preterm, taking place before 37 weeks gestation. Preterm birth can result from several conditions, including preterm labor, preterm rupture of the placental membrane, or preeclampsia.
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue.
› Verified 6 days ago
| Entity Name | Allied Digestive Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265831259 PECOS PAC ID: 5991027583 Enrollment ID: O20141210001569 |
News Archive
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Late-breaking data from the SPIRIT IV trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year.
Pregnancy can be a time of uncertainty for expecting mothers and their clinical care teams. Nearly 10 percent of births are preterm, taking place before 37 weeks gestation. Preterm birth can result from several conditions, including preterm labor, preterm rupture of the placental membrane, or preeclampsia.
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amir Hanna, MD Po Box 551420, Fort Lauderdale, FL 33355-1420 Ph: (200) 243-3839 | Amir Hanna, MD 175 Madison Ave, Mount Holly, NJ 08060-2038 Ph: (609) 261-1660 |
News Archive
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
Late-breaking data from the SPIRIT IV trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year.
Pregnancy can be a time of uncertainty for expecting mothers and their clinical care teams. Nearly 10 percent of births are preterm, taking place before 37 weeks gestation. Preterm birth can result from several conditions, including preterm labor, preterm rupture of the placental membrane, or preeclampsia.
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue.
› Verified 6 days ago
Nicole Tomkowich, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 | |
Dr. Sergey Moldavskiy, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave Fl 1, Mount Holly, NJ 08060 Phone: 609-914-6000 | |
Sarah F Campbell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave Fl 1, Mount Holly, NJ 08060 Phone: 609-914-6000 | |
Rupal Kalariya, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 120 Madison Ave, Suite E, Mount Holly, NJ 08060 Phone: 609-267-0700 | |
Dr. Robin T Thornton, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 120 Madison Ave, Mount Holly, NJ 08060 Phone: 609-261-1160 | |
Dr. John Lochiel Panico, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-267-0700 Fax: 609-261-4801 | |
Shruthi Balakrishna, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave Fl 1, Mount Holly, NJ 08060 Phone: 609-914-6000 |